000 | 01237 a2200337 4500 | ||
---|---|---|---|
005 | 20250517184840.0 | ||
264 | 0 | _c20181221 | |
008 | 201812s 0 0 eng d | ||
022 | _a1744-7593 | ||
024 | 7 |
_a10.1080/17425247.2018.1406917 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKourmatzis, A | |
245 | 0 | 0 |
_aAirway geometry, airway flow, and particle measurement methods: implications on pulmonary drug delivery. _h[electronic resource] |
260 |
_bExpert opinion on drug delivery _c03 2018 |
||
300 |
_a271-282 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAdministration, Inhalation |
650 | 0 | 4 |
_aAerosols _xadministration & dosage |
650 | 0 | 4 | _aDrug Delivery Systems |
650 | 0 | 4 | _aDry Powder Inhalers |
650 | 0 | 4 | _aForced Expiratory Flow Rates |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLung _xdrug effects |
650 | 0 | 4 | _aParticle Size |
650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xdrug therapy |
650 | 0 | 4 | _aRespiratory Function Tests |
700 | 1 | _aCheng, S | |
700 | 1 | _aChan, H-K | |
773 | 0 |
_tExpert opinion on drug delivery _gvol. 15 _gno. 3 _gp. 271-282 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1080/17425247.2018.1406917 _zAvailable from publisher's website |
999 |
_c27798972 _d27798972 |